Chun-Chen Shen¹, Kuo-Chen Cheng^1,2, Shin-Sung Chuang³ and Yin-Hsun Feng^1,4,5*

¹Department of Internal Medicine, Chi-Mei Medical Center, Yong Kang, Tainan, Taiwan
²Department of Safety Health and Environmental Engineering, Chung Hwa University of Medical Technology, Tainan, Taiwan
³Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan
⁴Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Yong Kang, Tainan, Taiwan
⁵Department of Nursing, Chung Hwa University of Medical Technology, Tainan, Taiwan

*Corresponding Author: Yin-Hsun Feng, Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Yong Kang, Tainan, Taiwan.

Received: January 14, 2018; Published: January 31, 2018

Citation: Yin-Hsun Feng., et al. “T Cell Lymphoblastic Lymphoma/Leukemia in a Pregnant Woman with Initial Presentation of Superior Vena Cava Syndrome”. Acta Scientific Cancer Biology 2.2 (2018).

Abstract

  Acute lymphoblastic lymphoma/leukemia is a rare occurrence during pregnancy but serious condition if it is left untreated. Many risks both for mother and fetus will be encountered when these neoplastic diseases accompany to pregnancy. Here we reported a 25-year-old, 16-weeks-pregnant woman with initial presentation of superior vena cava syndrome and respiratory distress. Prompt intensive chemotherapy right after early termination of pregnancy restored pulmonary function and successful remission of very aggressive hematological malignancy. In conclusion, treatment of very aggressive lymphoma in a pregnant woman should be highly individualized based on maternal safety and fetal outcome, especially life threatening situation encountered.

Keywords: Lymphoblastic Lymphoma; Pregnancy; Superior Vena Cava Syndrome

Copyright: © 2018 Yin-Hsun Feng., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.